Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT00552994
- Lead Sponsor
- Odense University Hospital
- Brief Summary
In stent neointimal hyperplasia may be less in the Cypher select plus stent compared to the Xience V stent in diabetic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- All diabetic patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby, Aalborg) can be included in the study.
Exclusion Criteria
- The patient will not participate
- The patient participates in other randomised stent studies
- Expected survival < 1 year
- Allergy to Aspirin, Clopidogrel or Ticlopidine
- Allergy to Sirolimus or ABT-578
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method In stent neointimal hyperplasia Within 10 months
- Secondary Outcome Measures
Name Time Method Peri-stent remodeling - Edge response to Cypher Select plus and Xience V stent - Malapposition - Angiographic late lumen loss Within 10 months
Trial Locations
- Locations (1)
Odense University Hospital
🇩🇰Odense, Denmark
Odense University Hospital🇩🇰Odense, Denmark